THE MARKET ACCESS SERVICES M&A MARKET
Market Access is becoming more complex, prompting more pharmaceutical companies to outsource commercialisation services to specialised providers.
Key factors driving this trend include:
- Increasing number of complex, niche, and specialised therapies for smaller patient groups
- Limited public budgets leading to greater competition for fewer resources
- AI integration throughout the drug commercialization process
- Pricing pressures and a global move towards value-based pricing
- Growing number of independent launches by small biopharma companies lacking in-house resources
- Rising demand for outsourced pharma services across the value chain
Combined with a new government that has promised funding stability for continued R&D and a commitment to strengthening underlying infrastructure, sector optimism has increased and the demand for M&A within Market Access services grows ever stronger.
To learn more about the key M&A trends taking shape this year in the Market Access space, read our latest paper.
If you would like to know more about the M&A landscape after reading this paper, or have any other questions on the wider pharmaceutical outsourcing space, please do get in touch -asultan@alvarezandmarsal.com.We would be delighted to discuss this report with you, including any implications these current and longer-term market themes may have on your business and overall shareholder objectives.
